HISUN PHARM HANGZHOU FDA Approval ANDA 206062

ANDA 206062

HISUN PHARM HANGZHOU

FDA Drug Application

Application #206062

Application Sponsors

ANDA 206062HISUN PHARM HANGZHOU

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION20MG/VIAL0DOXORUBICIN HYDROCHLORIDEDOXORUBICIN HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2019-05-13STANDARD

Submissions Property Types

ORIG1Null15

CDER Filings

HISUN PHARM HANGZHOU
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206062
            [companyName] => HISUN PHARM HANGZHOU
            [docInserts] => ["",""]
            [products] => [{"drugName":"DOXORUBICIN HYDROCHLORIDE","activeIngredients":"DOXORUBICIN HYDROCHLORIDE","strength":"20MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/13\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-05-13
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.